These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8112718)

  • 1. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study.
    García-Mayor RV; Andrade Olivie A; Fernández Catalina P; Castro M; Rego Iraeta A; Reparaz A
    Horm Res; 1993; 40(5-6):189-93. PubMed ID: 8112718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and pubertal development in transfusion-dependent children and adolescents with thalassaemia major and sickle cell disease: a comparative study.
    Soliman AT; elZalabany M; Amer M; Ansari BM
    J Trop Pediatr; 1999 Feb; 45(1):23-30. PubMed ID: 10191589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-biological and immunohaematological profile of patients with β-thalassemia in Tunisia: about 26 cases].
    Romdhane H; Amara H; Abdelkefi S; Souyeh N; Chakroun T; Jarrey I; Bouslama M; Belhedi S; Houissa B; Boughammoura L; Jemni Yacoub S
    Transfus Clin Biol; 2014 Dec; 21(6):309-13. PubMed ID: 25458984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of thyroid functions and its role in body growth in thalassemia major.
    Jain M; Sinha RS; Chellani H; Anand NK
    Indian Pediatr; 1995 Feb; 32(2):213-9. PubMed ID: 8635784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relationship between growth disorders and iron overload in children with beta-thalassemia major].
    Huang YL; Liu S; Xia T; Hao WG; Liang W; Sun X
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):603-6. PubMed ID: 18947480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth and management of short stature in thalassaemia major.
    Theodoridis C; Ladis V; Papatheodorou A; Berdousi H; Palamidou F; Evagelopoulou C; Athanassaki K; Konstantoura O; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():835-44. PubMed ID: 10091154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong.
    Kwan EY; Lee AC; Li AM; Tam SC; Chan CF; Lau YL; Low LC
    J Paediatr Child Health; 1995 Apr; 31(2):83-7. PubMed ID: 7794630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
    Moayeri H; Oloomi Z
    Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and sexual maturation in children with thalassemia major.
    Yesilipek MA; Bircan I; Oygür N; Ertug H; Yegin O; Güven AG
    Haematologica; 1993; 78(1):30-3. PubMed ID: 8491419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Program of hypertransfusion and chelation with desferrioxamine in 10 patients with thalassemia major].
    Albo C; Cabrera J; Dios A; Castro M; Ares C; Constenla I; López D
    Sangre (Barc); 1995 Dec; 40(6):441-5. PubMed ID: 8850225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V; Tanphaichitr VS; Mahasandana C; Assteerawatt A; Suwantol L; Veerakul G; Kankirawatana S; Pung-Amritt P; Suvatte V
    J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malnutrition and growth abnormalities in children with beta thalassemia major.
    Tienboon P; Sanguansermsri T; Fuchs GJ
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):356-61. PubMed ID: 9280002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age related IGF-I changes and IGF-I generation in thalassemia major.
    Soliman AT; Abushahin A; Abohezeima K; Khalafallah H; Adel A; Elawwa A; Elmulla N
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():278-83. PubMed ID: 21705978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and complications of thalassemia major in Guangxi, Southern China.
    Yin XL; Wu ZK; He YY; Zhou TH; Zhou YL; Zhang XH
    Pediatr Blood Cancer; 2011 Dec; 57(7):1174-8. PubMed ID: 21394896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency.
    Cavallo L; Gurrado R; Zecchino C; Manolo F; De Sanctis V; Cisternino M; Caruso-Nicoletti M; Galati M
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():845-9. PubMed ID: 10091155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc status in patients with major beta-thalassemia.
    Mehdizadeh M; Zamani G; Tabatabaee S
    Pediatr Hematol Oncol; 2008; 25(1):49-54. PubMed ID: 18231954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalassemia Minor and Major: Current Management.
    Choudhry VP
    Indian J Pediatr; 2017 Aug; 84(8):607-611. PubMed ID: 28435994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
    Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.